Earlier findings in mice treated with antisense oligonucleotides to diacylglycerol acyltransferase 2 offer further insights in attempting to understand the disconnect between resolution of hepatic steatosis and inflammatory/fibrogenic signaling in experimental NASH (47). The gene discussed is AWAT1; the disease is metabolic dysfunction-associated steatohepatitis.